2017
DOI: 10.1016/j.ejso.2016.05.030
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review on T3 laryngeal squamous cell carcinoma; still far from a consensus on the optimal organ preserving treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
23
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(25 citation statements)
references
References 32 publications
1
23
0
1
Order By: Relevance
“…[2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] In series with T1 midcord tumors the risk of local relapse is usually under 6%. [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] In series with T1 midcord tumors the risk of local relapse is usually under 6%.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] In series with T1 midcord tumors the risk of local relapse is usually under 6%. [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] In series with T1 midcord tumors the risk of local relapse is usually under 6%.…”
Section: Discussionmentioning
confidence: 99%
“…2,3 For more advanced carcinomas, the best local control is achieved with open partial surgery, that otherwise is associated to important perioperative morbidity and mainly indicated in younger patients. 7 Many series have reported the outcomes of TLM in laryngeal cancer, pointing out some of the risks and complications of this type of surgery. [8][9][10] Between them, an increased risk of local relapse in intermediate and advanced cases, especially when compared to open approaches.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Apart from its toxicity (different from the surgical one but not less dangerous in terms of potentially fatal complications and sequelae) [42,43], its application and success must rely on strict cooperation between different professional figures like surgeons (for diagnostic work-up, management of airway issues, and follow-up), radiation and medical oncologists, dieticians, and speech pathologists. However, even in the best MDT approach to CRT, it should always be made clear to the patient that such an organ preservation treatment sacrifices at least 20% of oncological outcome in the face of a higher chance of OP (at least compared to upfront TL) [44,45,46]. Moreover, in such a trade-off, it should always be quite clear to the MDT, as well as to the patient, that in case of oncological and/or functional failure, salvage surgery is still feasible but rarely by something less than TL [47,48,49,50,51].…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, functional outcomes in terms of quality of life, residual voice, and swallowing may be significantly different. However, prospective studies comparing different treatment strategies are still lacking and difficult to implement in the near future [1,2,3].…”
Section: Introductionmentioning
confidence: 99%